Study of Oxaliplatin and Taxotere in Prostate Cancer

NCT00260611 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Oxaliplatin
DRUG: Taxotere

Sponsor

University of Pittsburgh

Collaborators

[object Object]